Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q2 2025 · 10-Q
Revenue$826.20M$826.20M+8.4% vs Q2 2024 Net Income-$2.50M-$2.50MN/M vs Q2 2024 EPS Diluted-$0.02-$0.02N/M vs Q2 2024 Operating Income$111,700,000+31.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$57,900,000+3.6% Margins · derivedOperating margin13.5%+2.4 pt vs Q2 2024
Net margin-0.3%+1.7 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 5, 2025 · 36 d after period end